You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Objectives for this year include building a network of ELIXIR beacons, developing new features and security measures, and partnering with data owners.
As part of the deal, scientists from Philips' Intellispace Genomics development team will relocate to NYMC's biotechnology incubator in Westchester County.
The newly minted company offers panel, whole-genome and whole exome sequencing, as well as bioinformatics analysis and reporting services to oncologists.
The curriculum will cover computer science and experimental biology courses and offer opportunities for students to contribute to faculty research projects.
The partners have committed to analyzing coding mutations, driver non-coding mutations, and structural variations across tumor types for the project.
The awards are a result of Genome Canada and the Canadian Institutes of Health Research's 2015 Bioinformatics and Computational Biology Competition.
Unlike existing versions, CLARK-S allows mismatches between sample reads and reference databases, enabling it to map a larger proportion of input sequences.
The software combines the output of multiple data projection methods with gene signature information to help users identify meaningful biological processes.
The partners will evaluate various established research solutions including a number of variant calling methods for potential clinical use.
PNRI researchers will be able to analyze information from over 600,000 discrete tumor, blood, and urine samples from around 25,000 patients.
In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.